Certifications 2

SDS No.: 153499 V006.1
LOCTITE 510
Page 3 of 13
Declaration of the ingredients according to CLP (EC) No 1272/2008:
Hazardous components
CAS-No.
EC Number
REACH-Reg No.
content
Classification
1,1'-(methylenedi-p-
phenylene)bismaleimide
13676-54-5
237-163-4
5- < 10 %
Acute Tox. 3; Inhalation - dust
H331
Skin Sens. 1; Dermal
H317
Cumene hydroperoxide
80-15-9
201-254-7
> 1- < 2 %
Acute Tox. 4; Dermal
H312
STOT RE 2
H373
Acute Tox. 4; Oral
H302
Org. Perox. E
H242
Acute Tox. 3; Inhalation
H331
Aquatic Chronic 2
H411
Skin Corr. 1B
H314
Acetic acid, 2-phenylhydrazide
114-83-0
204-055-3
0,1- < 1 %
Acute Tox. 3; Oral
H301
Skin Irrit. 2
H315
Skin Sens. 1
H317
Eye Irrit. 2
H319
STOT SE 3; Inhalation
H335
Carc. 2
H351
For full text of the H - statements and other abbreviations see section 16 "Other information".
Substances without classification may have community workplace exposure limits available.
SECTION 4: First aid measures
4.1. Description of first aid measures
Inhalation:
Move to fresh air. If symptoms persist, seek medical advice.
Skin contact:
Rinse with running water and soap.
Obtain medical attention if irritation persists.
Eye contact:
Rinse immediately with plenty of running water (for 10 minutes), seek medical attention from a specialist.
Ingestion:
Rinse mouth, drink 1-2 glasses of water, do not induce vomiting, consult a doctor.
4.2. Most important symptoms and effects, both acute and delayed
EYE: Irritation, conjunctivitis.
RESPIRATORY: Irritation, coughing, shortness of breath, chest tightness.
SKIN: Rash, Urticaria.
4.3. Indication of any immediate medical attention and special treatment needed
See section: Description of first aid measures